US-based development-stage biopharmaceutical firm Sorrento Therapeutics has acquired Sherrington Pharmaceuticals (Sherrington), a company that provides chronic pain treatment for end-stage cancer patients and other severe pain indications. ...
Tags: Drug, Chronic Pain Treatment
London-based insurer RFIB Group (RFIB) has officially launched its new representative office in Durban, South Africa, as part of its strategy to boost its operation in the sub-Saharan insurance market. RFIB director John Hoggard has been ...
Tags: RFIB, Representative Office
The National Retail Federation announced it will host its first-ever Virtual Career Fair, designed to connect students and young professionals seeking entry-level careers and internships with leading retailers. Recruiters from companies ...
Tags: NRF, Career Fair
To help avoid unexpected loss of data and minimize downtime, Mitsubishi Electric Automation will now offer its customers remote access to a backup of their CNC machine tool information. The new service includes the creation and ...
Tags: Mitsubishi, Electric, CNC Data Backup
On September 26th, Fortune magazine released the results of assessment for 2013 Most Esteemed Chinese Companies. Ranked 15th , Baosteel is the only listed enterprise in iron and steel industry. Beginning in 2006, Fortune magazine focused ...
Tags: Baosteel, Fortune Magazine
MAX BioPharma has exclusively licensed the small molecule oxysterols from University of California, Los Angeles and Johns Hopkins University in the US. The pharmaceutical company has also received a Small Business Innovation Research ...
Japanese pharmaceutical firm PeptiDream and France-based Ipsen have expanded their research collaboration and license option agreement signed in April 2013 to develop peptide drugs to treat serious endocrinologic disease. The deal has now ...
Tags: PeptiDream, Ipsen, peptide drugs
US-based clinical stage biopharmaceutical firm Heat Biologics has filed an investigational new drug application (NDA) with the US Food and Drug Administration (FDA) for its second product candidate, HS-410, which will be evaluated in ...
Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
Biopharmaceutical company Trigemina will deliver clinical data on its drug candidate TI-001 for the treatment of chronic migraine at the ongoing 7th Annual Pain Therapeutics Summit East in Boston, Massachusetts. The presentation will ...
Tags: Migraine Drug, Medicine
NovaDigm Therapeutics has started a Phase Ib/IIa clinical trial of its NDV-3 vaccine, which is being developed to prevent episodes of vulvovaginal candidiasis (VVC) in patients with recurrent VVC (RVVC). Under the trial, which is a ...
Tags: NDV-3 Vaccine, NovaDigm
Geneva-based SGS Consumer Testing Services has released an updated program to help textile and footwear companies identify and detect substances of very high concern (SVHCs) in their products so that they might minimize risks associated ...
KULeuven (Katholieke Universiteit Leuven), nanoelectronics research center Imec of Leuven, Belgium and the National Institute of Advanced Industrial Science and Technology (AIST) of Tsukuba, Japan have developed a solid-phase epitaxy ...
US-based DiscoveRx’s BioSeek division launched BioMAP panel, a primary human cell-based assay platform, for oncology research. The BioMAP panel comprising primary human cell-based tumor-host model systems allows the researchers to ...
Tags: Oncology Research, Biomap Panel
US-based biopharmaceutical firm Cubist Pharmaceuticals has completed the acquisition of Trius Therapeutics, which is focused on the development of antibiotics, for about $704m. The acquisition of Trius brings to Cubist a late-stage ...